Butterfly Network 144 Filing Signals Potential $39.8 Million Sale
65d ago|4 min readStandard
Fazen Markets Editorial Desk
Collective editorial team · methodology
butterfly-networkform-144
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD 24/5 on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. Vortex HFT is informational software — not investment advice. Past performance does not guarantee future results.
A Form 144 filing was submitted to the U.S. Securities and Exchange Commission on June 2, 2026, for Butterfly Network, Inc. The filing registers the potential sale of up to 8.6 million shares of common stock by corporate insiders. At the stock's closing price of $4.63 on June 2, the total value of the registered shares is approximately $39.8 million. The filing provides a 90-day window for the sale of these shares, a move closely watched for signals of insider sentiment.
Form 144 filings are required notices when corporate insiders—such as officers, directors, or major shareholders—plan to sell restricted or control securities. The filing indicates a declared intent to sell but does not guarantee a transaction will occur. For Butterfly Network, this filing arrives during a period of significant operational and financial pressure on the company.
The broader medical device sector, as tracked by the iShares U.S. Medical Devices ETF (IHI), has faced headwinds from moderated hospital capital expenditure budgets. IHI is down 4.2% year-to-date, underperforming the broader S&P 500 index. Butterfly Network's stock has declined 34% over the same period, magnifying the scrutiny on any significant insider transactions.
The catalyst for the filing is likely the imminent expiration of lock-up periods tied to previous equity compensation or corporate transactions. This is a routine liquidity event for executives and early investors, but the scale of the potential sale relative to the company's market capitalization of approximately $950 million introduces notable supply-side risk.
The filing specifies a maximum of 8,600,000 shares available for potential sale. Butterfly Network's average 30-day trading volume is approximately 1.2 million shares. A sale of the entire block would represent over seven days of average trading volume, a substantial amount that could exert downward pressure on the stock price if not managed carefully.
The company's stock performance reveals the challenging environment. Butterfly Network shares closed at $4.63 on June 2, a 52-week low. The stock's performance diverges sharply from the NASDAQ Biotechnology Index (NBI), which is up 2.5% for the year. The table below illustrates the price decline over key periods.
| Period | Butterfly Network (BFLY) Performance |
|---|---|
| Year-to-Date (YTD) | -34% |
| Prior 30 Days | -11% |
| Since 52-Week High ($8.90) | -48% |
Butterfly Network reported a cash and equivalents balance of $165.3 million in its most recent quarterly filing. The potential $39.8 million sale represents a liquidity event for the sellers, not a capital raise for the company.
Large-scale insider selling can signal a lack of confidence in near-term appreciation prospects, potentially leading to increased volatility for Butterfly Network [BFLY]. The medical device sector is highly competitive, and sustained selling could be interpreted as skepticism regarding Butterfly's ability to gain market share against larger rivals like GE HealthCare [GEHC] and Philips [PHG]. These established players may benefit if investor capital rotates out of speculative names.
A key counter-argument is that Form 144 filings are often pre-scheduled for tax planning, portfolio diversification, or personal financial management and do not necessarily reflect a bearish outlook on the business. The sales may be executed gradually through pre-arranged trading plans to minimize market impact.
Positioning data from the options market shows a recent increase in put option volume for BFLY, suggesting some traders are hedging against further downside. Flow tracking indicates that while institutional long-term holders have largely maintained positions, short-term momentum traders have been reducing exposure.
The primary near-term catalyst is the execution of the sales themselves. Investors should monitor daily trading volumes and any filings for Form 4, which reports actual transactions, to gauge the pace and price of the disposals.
Butterfly Network's next quarterly earnings report, scheduled for late July 2026, will be critical. Key metrics to watch include revenue growth for its handheld ultrasound devices and the burn rate of its cash reserves. The company must demonstrate a path to profitability to rebuild investor confidence.
From a technical analysis perspective, the $4.50 level represents a key support zone. A sustained break below this level on heavy volume could trigger further selling, while a hold above it, especially amid the selling pressure, would be a technically positive signal.
A Form 144 is a mandatory SEC filing that signals an insider's intention to sell restricted or control securities. It is not a confirmation of a sale but a declaration of the legal ability to sell within a 90-day window. The filing requires the seller to meet specific conditions, including holding the securities for a predetermined period, and is often used for shares acquired through employee compensation plans.
The potential sale of 8.6 million shares is significant relative to the company's float. In November 2025, a smaller Form 144 filing for approximately 2 million shares preceded a 7% stock decline over the following month when sales were executed. The current filing is over four times larger, suggesting a more substantial test of market appetite for the stock in the current weaker price environment.
For retail investors, large insider sales can serve as a cautionary data point but should not be the sole factor in an investment decision. It is essential to differentiate between planned, diversified selling and a reaction to undisclosed negative news. Retail investors should focus on the company's upcoming fundamental performance, particularly revenue growth and cash flow, to assess the long-term thesis independently of insider trading activity.
The filing introduces significant near-term overhang for Butterfly Network stock amid an already challenging year.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
Vortex HFT is our free MT4/MT5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. Trades 24/5.
Position yourself for the macro moves discussed above
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.